Table 1.
Characteristics of the contributing studies.
| Study acronym | Location and Type of study | Year of diagnosis | Number of cases (N = 5964)a | Deaths (%) | 5-year mortality (%) | Median Follow-up in years (range)b | Data availablec |
|---|---|---|---|---|---|---|---|
| AUS |
Australia Case-control |
2002–2005 | 1159 | 819 (71%) | 605 (52%) | 10.8 (9.1–13.5) | B/C/D/G/H |
| DOV |
USA Case-control |
2002–2009 | 1040 | 624 (60%) | 440 (43%) | 11.7 (7.5–16.1) | B/C |
| HAW |
USA Case-control |
1994–2008 | 378 | 218 (58%) | 149 (40%) | 10.2 (4.0–21.0) | B/C/D/G/H |
| LAC |
USA Case-control |
1994–2004 | 639 | 439 (69%) | 281 (44%) | 15.9 (4.1–26.2) | B/C/D/G |
| MAL |
Europe Case-control |
1994–1998 | 93 | 74 (80%) | 50 (55%) | 22.3 (20.2–23.4) | B/C |
| MCC |
Australia Cohort |
1990–2008 | 99 | 74 (75%) | 56 (58%) | 19.5 (11.0–25.7) | B/C/H |
| NEC |
USA Case-control |
1992–2008 | 1386 | 788 (57%) | 536 (39%) | 12.9 (6.9–22.8) | B/C/D |
| NJO |
USA Case-control |
2005–2008 | 196 | 116 (59%) | 73 (38%) | 9.0 (5.9–11.2) | B/C/G |
| OPL |
Australia Case-only |
2012–2015 | 718 | 373 (52%) | 316 (44%) | 6.6 (0.8–8.7) | B/C/D/G/H |
| POL |
Europe Case-control |
2000–2003 | 256 | 140 (55%) | 129 (53%) | 5.3 (0.1–7.2) | B/C |
AUS Australian Ovarian Cancer Study, DOV Diseases of the Ovary and their Evaluation Study, HAW Hawaii Ovarian Cancer Study, LAC Los Angeles County Case–Control Studies of Ovarian Cancer, MAL Danish Malignant Ovarian Tumour Study, MCC Melbourne Collaborative Cohort Study, NEC New England Case–Control Study of Ovarian Cancer, NJO New Jersey Ovarian Cancer Study, OPL Ovarian Cancer Prognosis and Lifestyle Study, POL Polish Ovarian Cancer Study.
aWomen who completed the diet questionnaire > 2 years after diagnosis are excluded; deaths within the first year are included.
bAmong women who had not died.
cB = Black tea, C = Coffee – all, D = Decaffeinated vs. caffeinated coffee, G = Green tea, H = Herbal tea; All except MAL and POL also had total caffeine intake.